Aerogen products win SFDA approval
Aerogen has received a receipt from the State Food and Drug Administration (SFDA) to commercialize its Aeroneb Pro and Aeroneb Go products.
The Aeroneb Pro, which utilizes a patented vibrating mesh technology, is a multi-patient nebuliser creating a fine particle aerosol for targeted drug delivery to the lungs to treat a broad spectrum of patient respiratory conditions.
Aeroneb Go which also uses the same vibrating technology is used for inhaled drug treatment in the home.
Gaelmed, a distribution partner of Aerogen, will sell Aeroneb Pro and the Aeroneb Go within China.
Related Insight
Suppliers Directory
Specialty Devices
Anesthesia & Respiratory Devices
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Drug Delivery Devices
Orthopedic Devices
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.